Mar Santos-Sebastián
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mar Santos-Sebastián has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Alicia Hernanz-Lobo
Department of Pediatric Infectious Diseases, Gregorio Marañón University Hospital, Madrid, Spain
2 shared publications - Antoni Soriano-Arandes
Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d’Hebron University Hospital, Barcelona, Spain
2 shared publications - Begoña Santiago-García
Pediatric Infectious Diseases Department, Gregorio Marañón University Hospital, Madrid, Spain
2 shared publications - Elena María Rincón-López
Hospital General Universitario Gregorio Marañón
2 shared publications - Jesús Saavedra-Lozano
Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón(IiSGM), Complutense University of Madrid, Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain
2 shared publications - María Espiau
Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d’Hebron University Hospital, Barcelona, Spain
2 shared publications
Latest Publications
- 31 August 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Clinical and Epidemiologic Features of Pediatric Strongyloidiasis in Spain
Background: Data about pediatric strongyloidiasis are scarce in our setting. Methods: We conducted a retrospective multicenter registry of cases of pediatric strongyloidiasis in Spain. Results: Among 138 cases, 76% were travelers/migrants. Overall, 32% were symptomatic, and 35% had eosinophilia (higher in symptomatic patients, P < 0.05). Confirmed diagnosis occurred in 10% (stool polymerase chain reaction), while 90% were probable (serology). Ivermectin was the first therapy (98%). Adequate follow-up after treatment was achieved in only 36%. Conclusions: One-fourth of cases were authochthonous, so screening should not be limited to migrant children. Mild eosinophilia could help to detect asymptomatic cases.
- 31 August 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Clinical and Epidemiologic Features of Pediatric Strongyloidiasis in Spain
Background: Data about pediatric strongyloidiasis are scarce in our setting. Methods: We conducted a retrospective multicenter registry of cases of pediatric strongyloidiasis in Spain. Results: Among 138 cases, 76% were travelers/migrants. Overall, 32% were symptomatic, and 35% had eosinophilia (higher in symptomatic patients, P < 0.05). Confirmed diagnosis occurred in 10% (stool polymerase chain reaction), while 90% were probable (serology). Ivermectin was the first therapy (98%). Adequate follow-up after treatment was achieved in only 36%. Conclusions: One-fourth of cases were authochthonous, so screening should not be limited to migrant children. Mild eosinophilia could help to detect asymptomatic cases.
- Open Access
- 6 September 2024
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 57 (6) , 937-946
Diagnostic potential of combining plasma biomarkers of tissue damage and inflammation in pediatric TB
- 6 September 2024
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 57 (6) , 937-946
Open AccessDiagnostic potential of combining plasma biomarkers of tissue damage and inflammation in pediatric TB
- 8 July 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (10) , e358-e362
Lock Therapy for Treatment and Prevention of Catheter-related Infections
- 8 July 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (10) , e358-e362
Lock Therapy for Treatment and Prevention of Catheter-related Infections
- Open Access
Clinical Outcomes of a Zika Virus Mother–Child Pair Cohort in Spain
Background: Zika virus (ZIKV) infection has been associated with congenital microcephaly and other neurodevelopmental abnormalities. There is little published research on the effect of maternal ZIKV infection in a non-endemic European region. We aimed to describe the outcomes of pregnant travelers diagnosed as ZIKV-infected in Spain, and their exposed children. Methods: This prospective observational cohort study of nine referral hospitals enrolled pregnant women (PW) who travelled to endemic areas during their pregnancy or the two previous months, or those whose sexual partners visited endemic areas in the previous 6 months. Infants of ZIKV-infected mothers were followed for about two years. Results: ZIKV infection was diagnosed in 163 PW; 112 (70%) were asymptomatic and 24 (14.7%) were confirmed cases. Among 143 infants, 14 (9.8%) had adverse outcomes during follow-up; three had a congenital Zika syndrome (CZS), and 11 other potential Zika-related outcomes. The overall incidence of CZS was 2.1% (95%CI: 0.4–6.0%), but among infants born to ZIKV-confirmed mothers, this increased to 15.8% (95%CI: 3.4–39.6%). Conclusions: A nearly 10% overall risk of neurologic and hearing adverse outcomes was found in ZIKV-exposed children born to a ZIKV-infected traveler PW. Longer-term follow-up of these children is needed to assess whether there are any later-onset manifestations.
Open AccessClinical Outcomes of a Zika Virus Mother–Child Pair Cohort in Spain
Background: Zika virus (ZIKV) infection has been associated with congenital microcephaly and other neurodevelopmental abnormalities. There is little published research on the effect of maternal ZIKV infection in a non-endemic European region. We aimed to describe the outcomes of pregnant travelers diagnosed as ZIKV-infected in Spain, and their exposed children. Methods: This prospective observational cohort study of nine referral hospitals enrolled pregnant women (PW) who travelled to endemic areas during their pregnancy or the two previous months, or those whose sexual partners visited endemic areas in the previous 6 months. Infants of ZIKV-infected mothers were followed for about two years. Results: ZIKV infection was diagnosed in 163 PW; 112 (70%) were asymptomatic and 24 (14.7%) were confirmed cases. Among 143 infants, 14 (9.8%) had adverse outcomes during follow-up; three had a congenital Zika syndrome (CZS), and 11 other potential Zika-related outcomes. The overall incidence of CZS was 2.1% (95%CI: 0.4–6.0%), but among infants born to ZIKV-confirmed mothers, this increased to 15.8% (95%CI: 3.4–39.6%). Conclusions: A nearly 10% overall risk of neurologic and hearing adverse outcomes was found in ZIKV-exposed children born to a ZIKV-infected traveler PW. Longer-term follow-up of these children is needed to assess whether there are any later-onset manifestations.
- Open Access
- 19 October 2019
- Published by Elsevier in Anales de Pediatría
- Vol. 91 (5) , 296-306
Invasive meningococcal disease in children and adults in a tertiary level hospital. Recent epidemiology and prognostic factors
- 19 October 2019
- Published by Elsevier in Anales de Pediatría
- Vol. 91 (5) , 296-306
Open AccessInvasive meningococcal disease in children and adults in a tertiary level hospital. Recent epidemiology and prognostic factors